Assessment of lornoxicam as a mouth dissolving film in management of post extraction pain-A randomized control trial

Background: Mouth dissolving film (MDF) is a fast-dissolving drug delivery system that provides a practical means to administer drugs not just to special populations with swallowing difficulties but also to the general public. MDFs are novel dosage forms that dissolve and disintegrate quickly within...

Full description

Bibliographic Details
Main Authors: M Aparna Vijayan, K P Mahesh, Karthikeya Patil
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Journal of Indian Academy of Oral Medicine and Radiology
Subjects:
Online Access:http://www.jiaomr.in/article.asp?issn=0972-1363;year=2022;volume=34;issue=3;spage=263;epage=267;aulast=Vijayan
_version_ 1811240696866144256
author M Aparna Vijayan
K P Mahesh
Karthikeya Patil
author_facet M Aparna Vijayan
K P Mahesh
Karthikeya Patil
author_sort M Aparna Vijayan
collection DOAJ
description Background: Mouth dissolving film (MDF) is a fast-dissolving drug delivery system that provides a practical means to administer drugs not just to special populations with swallowing difficulties but also to the general public. MDFs are novel dosage forms that dissolve and disintegrate quickly within the mouth. Aim: To assess the efficacy of lornoxicam mouth dissolving film as a potent analgesic and drug delivery system and compare it with the aceclofenac tablet in the management of post-extraction pain. Methodology: The study group comprised 60 subjects of either sex of age group 20–50 years who were divided into an experimental group (group A) and a control group (group B). Group A was administered lornoxicam MDF and group B was administered aceclofenac tablets. Pre-treatment and post-treatment pain assessments were recorded using a visual analog scale (VAS) and an oral pain scale (OPS). Results: In a comparison of the mean value of pre-treatment VAS and VAS after 24 h, the percentage of pain reduction in group A was 86.66%, and in group B was 75%. When comparing the mean value of pre-treatment OPS and OPS after 24 h, the percentage of pain reduction in group A was 93.33% and in group B was 75%. These results were statistically significant, with a P value of 0.00 in both groups. Conclusion: Lornoxicam as an MDF showed promising results in managing post-extraction pain. The potential delivery of lornoxicam through the MDF was safe, with better patient compliance, and no reported cases of adverse effects.
first_indexed 2024-04-12T13:24:51Z
format Article
id doaj.art-3530c3c314bf45d5a97b414aff7805c5
institution Directory Open Access Journal
issn 0972-1363
language English
last_indexed 2024-04-12T13:24:51Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Indian Academy of Oral Medicine and Radiology
spelling doaj.art-3530c3c314bf45d5a97b414aff7805c52022-12-22T03:31:21ZengWolters Kluwer Medknow PublicationsJournal of Indian Academy of Oral Medicine and Radiology0972-13632022-01-0134326326710.4103/jiaomr.jiaomr_119_22Assessment of lornoxicam as a mouth dissolving film in management of post extraction pain-A randomized control trialM Aparna VijayanK P MaheshKarthikeya PatilBackground: Mouth dissolving film (MDF) is a fast-dissolving drug delivery system that provides a practical means to administer drugs not just to special populations with swallowing difficulties but also to the general public. MDFs are novel dosage forms that dissolve and disintegrate quickly within the mouth. Aim: To assess the efficacy of lornoxicam mouth dissolving film as a potent analgesic and drug delivery system and compare it with the aceclofenac tablet in the management of post-extraction pain. Methodology: The study group comprised 60 subjects of either sex of age group 20–50 years who were divided into an experimental group (group A) and a control group (group B). Group A was administered lornoxicam MDF and group B was administered aceclofenac tablets. Pre-treatment and post-treatment pain assessments were recorded using a visual analog scale (VAS) and an oral pain scale (OPS). Results: In a comparison of the mean value of pre-treatment VAS and VAS after 24 h, the percentage of pain reduction in group A was 86.66%, and in group B was 75%. When comparing the mean value of pre-treatment OPS and OPS after 24 h, the percentage of pain reduction in group A was 93.33% and in group B was 75%. These results were statistically significant, with a P value of 0.00 in both groups. Conclusion: Lornoxicam as an MDF showed promising results in managing post-extraction pain. The potential delivery of lornoxicam through the MDF was safe, with better patient compliance, and no reported cases of adverse effects.http://www.jiaomr.in/article.asp?issn=0972-1363;year=2022;volume=34;issue=3;spage=263;epage=267;aulast=Vijayanaceclofenacdrug delivery systemlornoxicampain measurementpost-operative pain
spellingShingle M Aparna Vijayan
K P Mahesh
Karthikeya Patil
Assessment of lornoxicam as a mouth dissolving film in management of post extraction pain-A randomized control trial
Journal of Indian Academy of Oral Medicine and Radiology
aceclofenac
drug delivery system
lornoxicam
pain measurement
post-operative pain
title Assessment of lornoxicam as a mouth dissolving film in management of post extraction pain-A randomized control trial
title_full Assessment of lornoxicam as a mouth dissolving film in management of post extraction pain-A randomized control trial
title_fullStr Assessment of lornoxicam as a mouth dissolving film in management of post extraction pain-A randomized control trial
title_full_unstemmed Assessment of lornoxicam as a mouth dissolving film in management of post extraction pain-A randomized control trial
title_short Assessment of lornoxicam as a mouth dissolving film in management of post extraction pain-A randomized control trial
title_sort assessment of lornoxicam as a mouth dissolving film in management of post extraction pain a randomized control trial
topic aceclofenac
drug delivery system
lornoxicam
pain measurement
post-operative pain
url http://www.jiaomr.in/article.asp?issn=0972-1363;year=2022;volume=34;issue=3;spage=263;epage=267;aulast=Vijayan
work_keys_str_mv AT maparnavijayan assessmentoflornoxicamasamouthdissolvingfilminmanagementofpostextractionpainarandomizedcontroltrial
AT kpmahesh assessmentoflornoxicamasamouthdissolvingfilminmanagementofpostextractionpainarandomizedcontroltrial
AT karthikeyapatil assessmentoflornoxicamasamouthdissolvingfilminmanagementofpostextractionpainarandomizedcontroltrial